Two Seattle-based health startups just announced a move that could significantly change how hospitals and insurers handle patient scheduling. And, like almost everything in the tech industry these days, artificial intelligence is at the heart of this story.
DexCare, a Seattle-based health technology company, announced the acquisition of Mila Health, a company from the same region that developed AI agents capable of calling and texting patients seeking medical appointments. The goal is straightforward: automate and speed up outreach to people who need to book care.
The two companies did not disclose the financial terms of the deal, but they made it clear the merger goes well beyond a simple acquisition — the idea is to combine technologies to solve a real, persistent problem in the digital health space. 🏥
DexCare already operates at scale, serving 57 million patients across the United States, while Mila Health brings agile technology that can be integrated into existing systems in a matter of hours. DexCare’s client roster includes industry heavyweights like Kaiser Permanente, Piedmont, Texas Health Resources, and Tampa General.
Together, the two want to prove that AI agents can go far beyond the basics — and that the path forward runs through solutions built specifically for healthcare, not generic models hastily adapted for the industry.
The problem nobody could really solve
Anyone who has tried to book a doctor’s appointment knows just how frustrating the process can be. You call, get stuck on hold, get a callback hours later, or worse — never hear back at all. On the provider side, things are just as rough: overwhelmed teams, long queues, and patients who give up before they even get seen.
This kind of bottleneck costs hospitals, clinics, and health insurers a fortune every year. This is exactly where the combination of DexCare and Mila Health aims to make a difference, using artificial intelligence to close this gap in a smarter and more scalable way than any manual solution could.
Receive the best innovation content in your email.
All the news, tips, trends, and resources you're looking for, delivered to your inbox.
By subscribing to the newsletter, you agree to receive communications from Método Viral. We are committed to always protecting and respecting your privacy.
DexCare has an interesting backstory. It was born about a decade ago as a spin-out from Providence‘s digital innovation group, a major healthcare organization. The original goal was to help health systems with digital patient acquisition, better coordinating institutional capacity and the appointment booking process. Today, the platform does much more than that: it helps organizations fill open time slots and manages information ranging from patient referral requirements to insurance protocols and scheduling logistics.
Mila Health, on the other hand, was built with a very clear objective: create AI agents that can communicate with patients naturally, whether through phone calls or text messages, to help them book appointments and answer questions about availability and care eligibility. It sounds simple, but the execution is what sets their technology apart.
Meanwhile, DexCare had already built a robust platform for patient scheduling at scale, connecting people to healthcare services nationwide. With tens of millions of patients in its system, the company has the data, infrastructure, and relationships with major health systems that few health startups can match. What was missing was precisely a proactive, automated communication layer — and Mila Health delivers exactly that.
So this acquisition isn’t about eliminating a competitor or simply expanding the portfolio: it’s about fitting two pieces together that form a much more complete solution. 🤝
How AI fits into the scheduling workflow
One of the most interesting aspects of Mila Health’s technology is implementation speed. According to both companies, their artificial intelligence agents can be integrated into existing systems in a matter of hours — not weeks, not months. This matters because one of the biggest barriers to adopting new technology in healthcare is the complexity of integrating with legacy systems, those old, heavy-duty platforms hospitals and clinics still use to manage medical records, schedules, and patient data.
When a solution can plug into that environment without requiring a complete infrastructure overhaul, it has a much better shot at being adopted at scale.
In practice, here’s what happens: when a patient shows interest in booking an appointment — whether by filling out an online form or through a payer’s digital channel — Mila Health’s AI agent kicks in automatically. It calls or texts the patient, collects the necessary information, checks availability on the provider’s schedule, and confirms the booking. This entire cycle, which previously depended on call centers and support teams, now runs autonomously and is available around the clock. 🕐
One of the executives behind the deal put it well. Shailu Verma, co-founder and CEO of Mila, pointed out that healthcare cannot rely on off-the-shelf, generic language models because they are unpredictable and cannot be audited. According to him, with DexCare, providers and payers can configure an AI agent to complete tasks for which there simply aren’t enough staff members available.
Matt Blosl, CEO of DexCare, added to that by highlighting a common problem in the industry: AI solutions are everywhere, but health systems quickly realize that building the infrastructure, scaling the pilot, and managing the guardrails of an AI agent is unsustainable to do alone. That is precisely the gap this new technology combination aims to fill.
Why focus makes all the difference
What sets this approach apart from the generic AI solutions that have tried to break into healthcare before is focus. Large, general-purpose language models are impressive, but when they need to handle the nuances of a structured healthcare system, they stumble on details that make all the difference in the real world. Mila Health built its technology with this specific context in mind, which means the agents know how to interact with patients in sensitive situations, how to handle insurance information, and how to ensure that all data exchanged complies with medical privacy regulations.
A look at the history behind both companies
To understand the weight of this acquisition, it’s worth knowing a bit more about each company’s background. DexCare has raised roughly $146 million over the course of its journey, with the most recent round in 2023 totaling $75 million — one of the largest raises that year in the region. The company also has experience with acquisitions: in 2022, it purchased Womp, a Bellingham, Washington-based e-commerce platform that, fun fact, originally started as a snow reporting service.
DexCare has been a finalist in the Health Innovation of the Year category at tech industry awards and ranks among the top startups in the Pacific Northwest, with approximately 133 employees according to market data platforms.
Mila Health has a more recent and leaner track record. It launched in January 2024, founded by Shailu Verma, who previously served as director of product for strategy and innovation at a major American health insurer. Verma also brings five years of experience at Amazon Web Services, where he worked as a product manager until 2021. Mila participated in an advanced technology accelerator program and, interestingly, appears not to have raised traditional venture capital, operating with a team of about 25 employees. In other words, a small, agile company with absolute focus on product.
What this move says about the future of health startups
The acquisition of Mila Health by DexCare is a clear signal of a trend gaining momentum in the digital health market: the specialization of artificial intelligence. For a long time, the dominant narrative was that large AI models would solve everything — that you could just plug a generic tool into any industry and problems would automatically disappear. What actually happened was different. The use cases that truly worked were the ones where the technology was developed or adapted with depth for the specific context of application.
In healthcare, this is even more apparent, because the consequences of a mistake aren’t just financial — they directly affect people’s lives.
Another important aspect of this move is what it reveals about the current state of health startups. After years of heavy investment in the sector, the market is becoming more selective. Investors and major health systems want to see concrete results, not just tech promises. In this environment, it makes total sense for companies with complementary technologies to join forces and build stronger value propositions that are hard to ignore. DexCare, with its scale and established relationships, and Mila Health, with its conversational AI agent technology for patient scheduling, form exactly that kind of combination. 🚀
For markets outside the U.S. that also face massive challenges in accessing appointments and managing wait times in both public and private systems, this type of solution serves as an important reference point. Even though DexCare and Mila Health’s operations are focused on the United States, the logic behind the technology — using artificial intelligence agents to automate and humanize the patient scheduling process — applies perfectly to other markets.
What will determine the success or failure of these initiatives, here or anywhere else, is the same thing: the ability to deliver an experience that works well for people on both sides — the patient and the healthcare provider. And, so far, the combination of these two startups seems to be on the right track to do exactly that.
